167 related articles for article (PubMed ID: 35849548)
21. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related peptide and primary hyperparathyroidism.
Testini M; Gurrado A; Lissidini G; Piccinni G; Greco L; Basile F; Biondi A
Front Biosci (Schol Ed); 2010 Jan; 2(1):299-312. PubMed ID: 20036948
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
24. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
25. Case report: lady with bone pains for 5 years-parathyroid carcinoma.
Rizwan A; Jamal A; Uzzaman M; Fatima S
BMC Res Notes; 2018 Aug; 11(1):617. PubMed ID: 30157930
[TBL] [Abstract][Full Text] [Related]
26. Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma.
Gomes Lda S; Kulak CA; Costa TM; Vasconcelos EC; Carvalho Md; Borba VZ
Arch Endocrinol Metab; 2015 Feb; 59(1):84-8. PubMed ID: 25926120
[TBL] [Abstract][Full Text] [Related]
27. Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Kim SS; Jeon YK; Lee SH; Kim BH; Kim SJ; Kim YK; Kim IJ
Korean J Intern Med; 2014 May; 29(3):383-7. PubMed ID: 24851075
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine thymic carcinoma metastatic to the parathyroid gland that was reimplanted into the forearm in patient with multiple endocrine neoplasia type 1 syndrome: a challenging management dilemma.
Shifrin AL; LiVolsi VA; Zheng M; Lann DE; Fomin S; Naylor EC; Mencel PJ; Fay AM; Erler BS; Matulewicz TJ
Endocr Pract; 2013; 19(6):e163-7. PubMed ID: 24014011
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine Carcinoma of the Endometrium with Ectopic Secretion of Parathyroid Hormone Presenting as Hypercalcemia- Related Posterior Reversible Encephalopathy syndrome: A Case Report.
Lin W; Lin YH; Gao HW; Chen IF; Ko CA; Tsai CK; Lin YK
Acta Neurol Taiwan; 2022 Jan; 31(1)():36-40. PubMed ID: 34988952
[TBL] [Abstract][Full Text] [Related]
30. Misleading clinical presentation of carcinoid syndrome.
Famerée L; Van Lier C; Borbath I; Yildiz H; Lemaire J; Baeck M
Acta Gastroenterol Belg; 2021; 84(3):501-503. PubMed ID: 34599576
[TBL] [Abstract][Full Text] [Related]
31. Four-dimensional computed tomography scan utility in parathyroidectomy for primary hyperparathyroidism with low baseline intact parathyroid hormone.
Rameau A; Eng S; Vu J; Saket R; Jun P; Friduss M
Laryngoscope; 2017 Jun; 127(6):1476-1482. PubMed ID: 27515539
[TBL] [Abstract][Full Text] [Related]
32. Primary hyperparathyroidism and parathyroid hormone-related protein.
Horwitz MJ; Bilezikian JP
Curr Opin Rheumatol; 1994 May; 6(3):321-8. PubMed ID: 8060769
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
34. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia.
Ohira S; Itoh K; Shiozawa T; Horiuchi A; Ono K; Takeuchi H; Hosoda W; Konishi I
Int J Gynecol Pathol; 2004 Oct; 23(4):393-7. PubMed ID: 15381910
[TBL] [Abstract][Full Text] [Related]
35. Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene.
VanHouten JN; Yu N; Rimm D; Dotto J; Arnold A; Wysolmerski JJ; Udelsman R
J Clin Endocrinol Metab; 2006 Feb; 91(2):580-3. PubMed ID: 16263810
[TBL] [Abstract][Full Text] [Related]
36. Complete Tumor Resection for a Hepatocellular Carcinoma Secreting Parathyroid Hormone-related Peptide.
Kim EK; Kim JS; Shin KC; Lee GT; Han CJ; Kim SB; Ku YH
Korean J Gastroenterol; 2015 Aug; 66(2):122-6. PubMed ID: 26289247
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland.
Iguchi H; Miyagi C; Tomita K; Kawauchi S; Nozuka Y; Tsuneyoshi M; Wakasugi H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2653-7. PubMed ID: 9709927
[TBL] [Abstract][Full Text] [Related]
38. An unusual case of malignancy-related hypercalcemia.
Doyle MA; Malcolm JC
Int J Gen Med; 2013; 7():21-7. PubMed ID: 24353437
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
40. Tumors of the parathyroid gland and circulating parathyroid hormone-related protein associated with persistent hypercalcemia.
Rosol TJ; Capen CC
Toxicol Pathol; 1989; 17(2):346-56. PubMed ID: 2675285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
